Seeing is believing: Monitoring real time changes during cell division

November 19, 2018

Scientist have cast new light on the behaviour of tiny hair-like structures called cilia found on almost every cell in the body.

Cilia play important roles in human development and disease. Akin to tiny antennae, they act as cell timers keeping the brakes on cell division until the right growth cues are received.

Malfunction of cilia leads to many human diseases such as polycystic kidney disease and cancer.

In the study published in Developmental Cell, researchers from the Universities of Edinburgh and Lancaster developed a multi-component fluorescent biosensor that allows users to 'light up' both cilia and cells that are actively dividing simultaneously. This is important because the machinery that drives cilia growth and cell division are shared.

Dr Pleasantine Mill of the University of Edinburgh said: "This powerful new tool will allow us to investigate cilia function in human disease in unprecedented detail."

Cilia are important in embryonic development shaping the size of organs, like our brains and lungs. However in adults both loss and hyperactivity in these crucial signalling centres is implicated in cancer cell proliferation and migration.

Dr Richard Mort of Lancaster University said: "It has long been known that the cilia and cell cycles are closely linked but until now it has been difficult to image these processes in parallel."

The new biosensor will allow researchers to carry out fundamental studies exploring how changes to cilia length and dynamics affect the speed of division and of tissue development.

Joint first author Dr Matthew Ford said: "This new resource will shed light at an individual cell level on the interplay between the cilia and cell cycles in development, regeneration and disease."

It is hoped these studies will help researchers build a more detailed picture of cilia in human disease and help monitor novel therapeutic approaches.
The study was funded by the Medical Research Council and the NC3Rs.

Lancaster University

Related Cancer Articles from Brightsurf:

New blood cancer treatment works by selectively interfering with cancer cell signalling
University of Alberta scientists have identified the mechanism of action behind a new type of precision cancer drug for blood cancers that is set for human trials, according to research published in Nature Communications.

UCI researchers uncover cancer cell vulnerabilities; may lead to better cancer therapies
A new University of California, Irvine-led study reveals a protein responsible for genetic changes resulting in a variety of cancers, may also be the key to more effective, targeted cancer therapy.

Breast cancer treatment costs highest among young women with metastic cancer
In a fight for their lives, young women, age 18-44, spend double the amount of older women to survive metastatic breast cancer, according to a large statewide study by the University of North Carolina at Chapel Hill.

Cancer mortality continues steady decline, driven by progress against lung cancer
The cancer death rate declined by 29% from 1991 to 2017, including a 2.2% drop from 2016 to 2017, the largest single-year drop in cancer mortality ever reported.

Stress in cervical cancer patients associated with higher risk of cancer-specific mortality
Psychological stress was associated with a higher risk of cancer-specific mortality in women diagnosed with cervical cancer.

Cancer-sniffing dogs 97% accurate in identifying lung cancer, according to study in JAOA
The next step will be to further fractionate the samples based on chemical and physical properties, presenting them back to the dogs until the specific biomarkers for each cancer are identified.

Moffitt Cancer Center researchers identify one way T cell function may fail in cancer
Moffitt Cancer Center researchers have discovered a mechanism by which one type of immune cell, CD8+ T cells, can become dysfunctional, impeding its ability to seek and kill cancer cells.

More cancer survivors, fewer cancer specialists point to challenge in meeting care needs
An aging population, a growing number of cancer survivors, and a projected shortage of cancer care providers will result in a challenge in delivering the care for cancer survivors in the United States if systemic changes are not made.

New cancer vaccine platform a potential tool for efficacious targeted cancer therapy
Researchers at the University of Helsinki have discovered a solution in the form of a cancer vaccine platform for improving the efficacy of oncolytic viruses used in cancer treatment.

American Cancer Society outlines blueprint for cancer control in the 21st century
The American Cancer Society is outlining its vision for cancer control in the decades ahead in a series of articles that forms the basis of a national cancer control plan.

Read More: Cancer News and Cancer Current Events is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to